Radiation therapy for bladder cancer
| dc.contributor.author | Çelik, OK | |
| dc.contributor.author | Sert, F | |
| dc.date.accessioned | 2025-04-10T10:29:42Z | |
| dc.date.available | 2025-04-10T10:29:42Z | |
| dc.description.abstract | The standart of care for muscle-invasive transitional-cell carcinoma of the bladder is radical cystectomy (RC) with bilateral pelvic lymph node dissection, even though RC can be associated with significant morbidity. Organ conservation by combined-modality therapy which commonplace in contemporary oncology, with succes in cancer of breast, anus, larynx, l, imb, esophagus and prostate come into question for bladeer cancers as well. Modern bladder-sparing strategies combine maximal transuretheral resection of bladder tumor (TUR-B) followed by an induction course of concurrent radiation therapy and sensitizing chemotherapy. Aproximately _ of surviving patients maintain their bladder using combined-modality therapy with long term survival rates comparable to those of RS. Organ-sparing combined-modality therapies can be recommended for selected bladder cancer patients as a safe and proven alternative. | |
| dc.identifier.issn | 2147-2270 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.14701/36392 | |
| dc.language.iso | Turkish | |
| dc.title | Radiation therapy for bladder cancer | |
| dc.type | Article |